Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion
Francis P. Worden(Georgetown University), Gregory T. Wolf(University of Michigan), Heidi Mason(University of Michigan), Avraham Eisbruch(University of Michigan–Ann Arbor), Mark E. Prince(University of Michigan), Jeremy M. G. Taylor(RAND Corporation), Carol R. Bradford(The Ohio State University), Jeffrey S. Moyer(Environmental Protection Agency), Julia S. Lee(University of Michigan), Christina Tsien(McGill University Health Centre), Norman D. Hogikyan(Michigan Medicine), Kevin S. Emerick(Massachusetts Eye and Ear Infirmary), Susan G. Urba(University of Michigan), Douglas B. Chepeha(University of Michigan), Tamara Miller(University of Michigan), Nancy E. Wallace(University of Michigan), Lubomir Hadjiski(University of Michigan), Amy Anne D. Lassig(University of Michigan), Theodoros N. Teknos(University Hospitals Seidman Cancer Center), Suresh K. Mukherji(University of Louisville)
Cited by 100
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
|Cell|2017|2.6k
Validation of an instrument to measure voice-related quality of life (V-RQOL)
|Journal of Voice|1999|1.1k
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766